Preventing the flu: Researchers looking for a new approach

Post author:gtmrick
Post published:June 5, 2015
Post category:Uncategorized

Lifetime: New approach to fighting influenza Advertise on CTVNews.ca

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

Vasomune Announces FDA Allowance of IND Application for AV-001 for the Treatment of Hospitalized Patients with COVID-19

Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

About

Vasomune Therapeutics 2020 © All Rights Reserved.